Pharmaceutical Technology, March 2012 Issue (PDF)
Tackling Solubility Challenges
Securing the Pharma Supply Chain
Defining Conflict of Interest
Genotoxic Impurities: A Q&A with Amgen's Bo Shen
Report from Brazil March 2012
Inside USP: A Holistic Approach to Supply-Chain Integrity
Evaluating Impurities in Drugs (Part II of III)
Formulation Development Forum: Programmable, Wirelessly Controlled Microchips for Drug Delivery
Generic Drug User Fees Mark a Step in the Right Direction
FDA Guides the Way to Biosimilars in the US
Communications Advances Present Manufacturer Challenges
FDA Encourages Whistleblowers, Just Not Its Own